The revenue of the oncology drugs segment of the pharmaceuticals market in Latin America was forecast to continuously increase between 2024 and 2028 by in total 5.8 billion U.S. dollars (+69.54 percent). After the sixth consecutive increasing year, the indicator is estimated to reach 14.1 billion U.S. dollars and therefore a new peak in 2028.
Revenue of the oncology drugs market in Latin America from 2016 to 2028
(in billion U.S. dollars)
Data provided by Statista Market Insights are estimates.
The oncology drugs market covers drugs to treat cancer, including chemotherapy and immunotherapy. These therapies are used for solid tumors and hematologic cancer. The medications in this market are mainly physician-administered drugs.
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
Company examples: Bristol-Myers Squibb, Roche, Merck & Co, Novartis, Johnson & Johnson
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Statista. (April 8, 2024). Revenue of the oncology drugs market in Latin America from 2016 to 2028 (in billion U.S. dollars) [Graph]. In Statista. Retrieved November 23, 2024, from https://www.statista.com/forecasts/1460297/revenue-oncology-drungs-market-latin-america
Statista. "Revenue of the oncology drugs market in Latin America from 2016 to 2028 (in billion U.S. dollars)." Chart. April 8, 2024. Statista. Accessed November 23, 2024. https://www.statista.com/forecasts/1460297/revenue-oncology-drungs-market-latin-america
Statista. (2024). Revenue of the oncology drugs market in Latin America from 2016 to 2028 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: November 23, 2024. https://www.statista.com/forecasts/1460297/revenue-oncology-drungs-market-latin-america
Statista. "Revenue of The Oncology Drugs Market in Latin America from 2016 to 2028 (in Billion U.S. Dollars)." Statista, Statista Inc., 8 Apr 2024, https://www.statista.com/forecasts/1460297/revenue-oncology-drungs-market-latin-america
Statista, Revenue of the oncology drugs market in Latin America from 2016 to 2028 (in billion U.S. dollars) Statista, https://www.statista.com/forecasts/1460297/revenue-oncology-drungs-market-latin-america (last visited November 23, 2024)
Revenue of the oncology drugs market in Latin America from 2016 to 2028 (in billion U.S. dollars) [Graph], Statista, April 8, 2024. [Online]. Available: https://www.statista.com/forecasts/1460297/revenue-oncology-drungs-market-latin-america
